NEW YORK (GenomeWeb News) – The US Department of Defense today said it has awarded the Institute for Systems Biology a contract for nearly $7.7 million to use next-generation sequencing to identify biomarkers that predict post-operative sepsis during the asymptomatic phase of infection.

The work is being done for DoD's Defense Threat Reduction Agency and is expected to be completed May 29, 2016, DoD said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.